Filgrastim biosimilar (Laboratorio Varifarma)

非格司亭生物类似药（Laboratorio Varifarma）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Laboratorio Varifarma)

Drug Alias Name非格司亭生物仿制药（Laboratorio Varifarma）rhG-CSF (Laboratorio Varifarma)Recombinant human granulocyte macrophage colony stimulating factor (Laboratorio Varifarma)重组人粒细胞刺激因子（Laboratorio Varifarma）Neutrofil

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesLaboratorio Varifarma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02